157 related articles for article (PubMed ID: 38682124)
1. Exploring Cardiovascular Comorbidities and Inflammatory Bowel Disease.
Lichtenstein GR
Gastroenterol Hepatol (N Y); 2024 Apr; 20(4):196. PubMed ID: 38682124
[No Abstract] [Full Text] [Related]
2. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
[TBL] [Abstract][Full Text] [Related]
3. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study.
Marin-Jimenez I; Bastida G; Forés A; Garcia-Planella E; Argüelles-Arias F; Sarasa P; Tagarro I; Fernández-Nistal A; Montoto C; Aguas M; Santos-Fernández J; Bosca-Watts MM; Ferreiro R; Merino O; Aldeguer X; Cortés X; Sicilia B; Mesonero F; Barreiro-de Acosta M
BMJ Open Gastroenterol; 2020; 7(1):e000351. PubMed ID: 32337054
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities of Psoriasis - Exploring the Links by Network Approach.
Sundarrajan S; Arumugam M
PLoS One; 2016; 11(3):e0149175. PubMed ID: 26966903
[TBL] [Abstract][Full Text] [Related]
5. Excessive weight--muscle depletion paradox and cardiovascular risk factors in outpatients with inflammatory bowel disease.
Andrade MI; Maio R; Dourado KF; Macêdo PF; Barreto Neto AC
Arq Gastroenterol; 2015; 52(1):37-45. PubMed ID: 26017081
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease and the risk of cardiovascular diseases.
Nuñez P; García Mateo S; Quera R; Gomollón F
Gastroenterol Hepatol; 2021 Mar; 44(3):236-242. PubMed ID: 33223261
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities in inflammatory bowel disease: a call for action.
Argollo M; Gilardi D; Peyrin-Biroulet C; Chabot JF; Peyrin-Biroulet L; Danese S
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):643-654. PubMed ID: 31171484
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular comorbidities in psoriasis (Review).
Branisteanu DE; Nicolescu AC; Branisteanu DC; Branisteanu CI; Dragoi AC; Bogdanici CM; Toader MP; Tucaliuc AL; Dimitriu A; Daogaru D; Pirvulescu RA; Porumb EA
Exp Ther Med; 2022 Feb; 23(2):152. PubMed ID: 35069833
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease and Cardiovascular Diseases.
Chen B; Collen LV; Mowat C; Isaacs KL; Singh S; Kane SV; Farraye FA; Snapper S; Jneid H; Lavie CJ; Krittanawong C
Am J Med; 2022 Dec; 135(12):1453-1460. PubMed ID: 36058305
[TBL] [Abstract][Full Text] [Related]
10. The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease.
Mantaka A; Tsoukali E; Fragkaki M; Karmiris K; Viazis N; Mantzaris GJ; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2020 May; 32(5):581-587. PubMed ID: 31922975
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals.
Aarestrup J; Jess T; Kobylecki CJ; Nordestgaard BG; Allin KH
J Crohns Colitis; 2019 Mar; 13(3):319-323. PubMed ID: 30321330
[TBL] [Abstract][Full Text] [Related]
12. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
Parekh R; Zhang X; Ungaro RC; Brenner EJ; Agrawal M; Colombel JF; Kappelman MD
Dig Dis Sci; 2022 Apr; 67(4):1271-1277. PubMed ID: 34181165
[TBL] [Abstract][Full Text] [Related]
13. A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel disease.
Somekh J; Peleg M; Eran A; Koren I; Feiglin A; Demishtein A; Shiloh R; Heiner M; Kong SW; Elazar Z; Kohane I
J Biomed Inform; 2016 Oct; 63():366-378. PubMed ID: 27522000
[TBL] [Abstract][Full Text] [Related]
14. Which hidradenitis suppurativa comorbidities should I take into account?
Tzellos T; Zouboulis CC
Exp Dermatol; 2022 Sep; 31 Suppl 1():29-32. PubMed ID: 35737874
[TBL] [Abstract][Full Text] [Related]
15. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
Lee MT; Mahtta D; Chen L; Hussain A; Al Rifai M; Sinh P; Khalid U; Nasir K; Ballantyne CM; Petersen LA; Virani SS
Am J Med; 2021 Aug; 134(8):1047-1051.e2. PubMed ID: 33812865
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities.
Potestio L; Tommasino N; Lauletta G; Martora F; Megna M
Dermatol Ther (Heidelb); 2024 Apr; 14(4):841-852. PubMed ID: 38592640
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities of hidradenitis suppurativa.
Porter ML; Kimball AB
Semin Cutan Med Surg; 2017 Jun; 36(2):55-57. PubMed ID: 28538744
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
19. Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis.
Chia AYT; Ang GWX; Chan ASY; Chan W; Chong TKY; Leung YY
Front Med (Lausanne); 2021; 8():737256. PubMed ID: 34604268
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Disease Comorbidities in Alzheimer's Disease.
Santiago JA; Potashkin JA
Front Aging Neurosci; 2021; 13():631770. PubMed ID: 33643025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
